Reduced receptor editing in lupus-prone MRL/1pr mice

被引:29
|
作者
Lamoureux, Jennifer L. [1 ]
Watson, Lisa C. [1 ]
Cherrier, Marie [1 ]
Skog, Patrick [1 ]
Nemazee, David [1 ]
Feeney, Ann J. [1 ]
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2007年 / 204卷 / 12期
关键词
D O I
10.1084/jem.20071268
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Journal of Experimental Medicine The initial B cell repertoire contains a considerable proportion of autoreactive specificities. The first major B cell tolerance checkpoint is at the stage of the immature B cell, where receptor editing is the primary mode of eliminating self-reactivity. The cells that emigrate from the bone marrow have a second tolerance checkpoint in the transitional compartment in the spleen. Although it is known that the second checkpoint is defective in lupus, it is not clear whether there is any breakdown in central B cell tolerance in the bone marrow. We demonstrate that receptor editing is less efficient in the lupus-prone strain MRL/lpr. In an in vitro system, when receptor-editing signals are given to bone marrow immature B cells by antiidiotype antibody or after in vivo exposure to membrane-bound self-antigen, MRL/lpr 3-83 transgenic immature B cells undergo less endogenous rearrangement and up-regulate recombination activating gene messenger RNA to a lesser extent than B10 transgenic cells. CD19, along with immunoglobulin M, is down-regulated in the bone marrow upon receptor editing, but the extent of down-regulation is fivefold less in MRL/lpr mice. Less efficient receptor editing could allow some autoreactive cells to escape from the bone marrow in lupus-prone mice, thus predisposing to autoimmunity.
引用
收藏
页码:2853 / 2864
页数:12
相关论文
共 50 条
  • [1] Receptor editing is impaired in lupus-prone MRL/lpr mice
    Feeney, Ann J.
    Lamoureux, Jennifer
    Nemazee, David
    Watson, Lisa
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S152 - S152
  • [2] IG VH GENE FAMILY REPERTOIRE OF PLASMA-CELLS DERIVED FROM LUPUS-PRONE MRL/1PR AND MRL/++ MICE
    KOMISAR, JL
    LEUNG, KY
    CRAWLEY, RR
    TALAL, N
    TEALE, JM
    JOURNAL OF IMMUNOLOGY, 1989, 143 (01): : 340 - 347
  • [3] Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/1pr lupus-prone mice
    de Lema, GP
    Maier, H
    Franz, TJ
    Escribese, M
    Chilla, S
    Segerer, S
    Camarasa, N
    Schmid, H
    Banas, B
    Kalaydjiev, S
    Busch, DH
    Pfeffer, K
    Mampaso, F
    Schlöndorff, D
    Luckow, B
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (12): : 3592 - 3601
  • [4] GENETIC-BASIS OF LUPUS DERMATOSES IN AUTOIMMUNE-PRONE MRL/1PR MICE
    KANAUCHI, H
    FURUKAWA, F
    IMAMURA, S
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (04) : 540 - 540
  • [5] POLYARTHRITIS IN MRL 1PR/1PR MICE
    PATAKI, A
    RORDORFADAM, C
    RHEUMATOLOGY INTERNATIONAL, 1985, 5 (03) : 113 - 120
  • [6] A BEHAVIORAL PROFILE OF AUTOIMMUNE LUPUS-PRONE MRL MICE
    SAKIC, B
    SZECHTMAN, H
    KEFFER, M
    TALANGBAYAN, H
    STEAD, R
    DENBURG, JA
    BRAIN BEHAVIOR AND IMMUNITY, 1992, 6 (03) : 265 - 285
  • [7] Modulation of intra-pulmonary TGF-β expression by mycophenolate mofetil in lupus prone MRL/1pr mice
    Guo, H
    Leung, JCK
    Chan, LYY
    Lui, SL
    Tsang, AWL
    Lai, KN
    LUPUS, 2005, 14 (08) : 583 - 592
  • [8] ANTIBODIES AGAINST MALONDIALDEHYDE (MDA) IN SERA OF MRL/1PR/1PR MICE
    YAHYA, MD
    PINNAS, JL
    MEINKE, GC
    FASEB JOURNAL, 1991, 5 (04): : A643 - A643
  • [9] Therapeutic Effects of Triptolide on Lupus-prone MRL/lpr Mice
    Huang, Xueqin
    Wen, Chengping
    Wei, Hua
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2018, 14 (05) : 681 - 688
  • [10] Exacerbation of Lupus symptoms in MRL/1pr mice following cyanobacterial injections.
    Kovacs, SA
    Mohan, AV
    FASEB JOURNAL, 2001, 15 (05): : A1066 - A1066